
Evommune, Inc. — Investor Relations & Filings
Evommune, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapies for immune-mediated chronic inflammatory diseases. The company employs leading-edge science and tissue-based insights to target the root causes and key drivers of inflammation. Evommune is advancing a pipeline of differentiated product candidates, aiming to improve patients' daily lives and prevent the long-term effects of uncontrolled inflammation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-07 | English | |
| 10-Q | 2026-05-07 | English | |
| 8-K | 2026-05-07 | English | |
| Regulatory Filings 2026 | 2026-04-27 | English | |
| 424B3 | 2026-04-24 | English | |
| ARS | 2026-04-21 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46723775 | 424B3 | 2026-05-07 | English | ||
| 46723774 | 10-Q | 2026-05-07 | English | ||
| 46723771 | 8-K | 2026-05-07 | English | ||
| 46723776 | Regulatory Filings 2026 | 2026-04-27 | English | ||
| 46723777 | 424B3 | 2026-04-24 | English | ||
| 46723781 | ARS | 2026-04-21 | English | ||
| 46723779 | DEFA14A | 2026-04-21 | English | ||
| 46723783 | DEF 14A | 2026-04-21 | English | ||
| 46723784 | S-1 | 2026-04-17 | English | ||
| 46723789 | 8-K | 2026-04-13 | English | ||
| 46723790 | S-8 | 2026-03-05 | English | ||
| 46723802 | 10-K | 2026-03-05 | English | ||
| 46723808 | 8-K | 2026-03-05 | English | ||
| 46723809 | Major Shareholding Notification 2026 | 2026-02-19 | English | ||
| 46723810 | Major Shareholding Notification 2026 | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
Evommune, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72596/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72596 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72596 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72596 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72596}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Evommune, Inc. (id: 72596)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.